Drug
Obexelimab
Obexelimab is a pharmaceutical drug with 4 clinical trials. Currently 4 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(100%)
Phase Distribution
Ph phase_2
2
50%
Ph phase_3
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Active, not recruiting3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 22 (50.0%)
Phase 32 (50.0%)
Trials by Status
active_not_recruiting375%
recruiting125%
Recent Activity
4 active trials
Showing 4 of 4
active_not_recruitingphase_3
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
NCT05662241
active_not_recruitingphase_2
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
NCT06564311
recruitingphase_2
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
NCT06559163
active_not_recruitingphase_3
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
NCT05786573
Clinical Trials (4)
Showing 4 of 4 trials
NCT05662241Phase 3
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
NCT06564311Phase 2
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
NCT06559163Phase 2
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
NCT05786573Phase 3
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4